Categories: NewsPharmaceutical

Improved Pharma Announces New High-Resolution Accurate Mass Spectrometry (LC-HRAMS) Capabilities (SCIEX 6600 TripleTOF)

This acquisition allows versatile analyses of pharmaceutical drug substances and drug products for both small molecules and large biologics.

WEST LAFAYETTE, Ind., Feb. 27, 2025 /PRNewswire/ — Liquid chromatography coupled with High-Resolution Accurate Mass Spectrometry (LC-HRAMS) is a powerful and flexible technique for the analyses of pharmaceutical drug substances and drug products. The technique separates and identifies analytes based on their retention times, mass-to-charge ratios, and parent ion fragmentation patterns. LC-HRAMS allows for the confident identification and quantitation of small molecule compounds, as well as large biologic molecules and polymers. Tandem HRAMS (MS/MS) is particularly useful for characterization and structural elucidation of unknown compounds in complex matrices, as well as the sequencing of proteins and peptides.

Improved Pharma has installed and operationally qualified a SCIEX TripleTOF® 6600 coupled to a SCIEX Exigent UHPLC system with UV detection. This system is a classic QTOF configuration comprised of a quadrupole mass filter collision cell, and Time of Flight mass filter. The TripleTOF® 6600 platform is equipped with ESI, APCI, and nano-spray ion sources, as well as an optional SelexION ion mobility stage. This instrument merges the very high resolving power of a Time of Flight (TOF) mass spectrometer with the high selectivity offered by MS/MS. The system is also sensitive enough for quantitative analyses of impurities or degradants at trace levels (ppm to ppb). 

About Improved Pharma: Improved Pharma is a research, consulting, and information company dedicated to improving pharmaceutical methods, formulations, and processes. Services include solid-state form studies, formulation design, synchrotron techniques, analytical testing, and expert consulting for the development and defense of intellectual property matters. The company was founded in 2006 by Stephen and Sarah Byrn, who also founded SSCI

Media Contact
Pam Smith, Improved Pharma, (765) 463-9951, info@improvedpharma.com, https://improvedpharma.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/improved-pharma-announces-new-high-resolution-accurate-mass-spectrometry-lc-hrams-capabilities-sciex-6600-tripletof-302387873.html

SOURCE Improved Pharma

Staff

Recent Posts

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

2 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

2 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

2 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

2 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

2 hours ago

PulseAI Secures Seed Funding to Advance AI-Driven ECG Diagnostics

BELFAST, Northern Ireland  , Jan. 12, 2026 /PRNewswire/ -- PulseAI, a rapidly emerging leader in…

2 hours ago